Patient Square Bets Big on NKTR: A Deep Dive for Investors
A prominent investor placed a sizable stake in Nektar Therapeutics, sparking questions about the stock's potential. T...
Uncover effective ways to earn cash back on purchases and make the most of your spending. Start saving with these tips!
22,766 articlesA prominent investor placed a sizable stake in Nektar Therapeutics, sparking questions about the stock's potential. T...
As large pharma hunts for GLP-1 and cardiovascular assets, three biotechs stand out as hot takeover targets. This rep...
A hedge fund trend today centers on a lean, two-name portfolio. INDUS Capital Partners boosted its bet on H World Gro...
Dive into Hamilton Lane's 2026 outlook with a clear, investor-focused breakdown. We explore revenue drivers, AUM grow...
SpaceX is positioning Starship V3 as the backbone of an IPO that could redefine private markets. Analysts say the nex...
A $500k annuity promises $2,950 a month for life, but a deeper look shows significant trade-offs in inflation, liquid...
A focused AI tilt ETF called CHAT can outperform broad tech in some periods, but XLK’s lower fees often matter more f...
A small-cap memory-interface provider, Lumina IP, reports gross margins near 80% in Q1 2026 as AI accelerators push d...
A 58-year-old divorcée with $1.4 million from a QDRO cannot roll the funds into an IRA until a long-ago court order i...
Two aviation giants, Delta Air Lines and United Airlines, compete for your portfolio. This guide breaks down their bu...
A broad crypto rout drags BitMine Immersion Technologies and Strategy lower as Ethereum tumbles about 7% in 24 hours....
With the December 2026 deadline approaching, investors with large capital gains are weighing Qualified Opportunity Fu...